Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Choice of Fluids in Severe Septic Patients - A Cost-effectiveness Analysis Informed by Recent Clinical Trials.

Farrugia A, Bansal M, Balboni S, Kimber MC, Martin GS, Cassar J.

Rev Recent Clin Trials. 2014;9(1):21-30.

2.

Hydroxyethyl starch in sepsis.

Haase NR.

Dan Med J. 2014 Jan;61(1):B4764.

PMID:
24393593
3.

Relative survival benefit and morbidity with fluids in severe sepsis - a network meta-analysis of alternative therapies.

Bansal M, Farrugia A, Balboni S, Martin G.

Curr Drug Saf. 2013 Sep;8(4):236-45. Review.

4.

Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis.

Haase N, Perner A, Hennings LI, Siegemund M, Lauridsen B, Wetterslev M, Wetterslev J.

BMJ. 2013 Feb 15;346:f839. doi: 10.1136/bmj.f839. Review.

5.

Colloids versus crystalloids for fluid resuscitation in critically ill patients.

Perel P, Roberts I, Ker K.

Cochrane Database Syst Rev. 2013 Feb 28;(2):CD000567. doi: 10.1002/14651858.CD000567.pub6. Review.

PMID:
23450531
6.

Fluid resuscitation with hydroxyethyl starches in patients with sepsis is associated with an increased incidence of acute kidney injury and use of renal replacement therapy: a systematic review and meta-analysis of the literature.

Serpa Neto A, Veelo DP, Peireira VG, de Assunção MS, Manetta JA, Espósito DC, Schultz MJ.

J Crit Care. 2014 Feb;29(1):185.e1-7. doi: 10.1016/j.jcrc.2013.09.031. Epub 2013 Oct 22. Review.

PMID:
24262273
7.

Colloids versus crystalloids for fluid resuscitation in critically ill patients.

Perel P, Roberts I.

Cochrane Database Syst Rev. 2012 Jun 13;(6):CD000567. doi: 10.1002/14651858.CD000567.pub5. Review. Update in: Cochrane Database Syst Rev. 2013;(2):CD000567.

PMID:
22696320
8.

Fluid resuscitation in sepsis: a systematic review and network meta-analysis.

Rochwerg B, Alhazzani W, Sindi A, Heels-Ansdell D, Thabane L, Fox-Robichaud A, Mbuagbaw L, Szczeklik W, Alshamsi F, Altayyar S, Ip WC, Li G, Wang M, Wludarczyk A, Zhou Q, Guyatt GH, Cook DJ, Jaeschke R, Annane D; Fluids in Sepsis and Septic Shock Group..

Ann Intern Med. 2014 Sep 2;161(5):347-55. doi: 10.7326/M14-0178. Review.

PMID:
25047428
9.

Intravenous fluids in sepsis: what to use and what to avoid.

Karakala N, Raghunathan K, Shaw AD.

Curr Opin Crit Care. 2013 Dec;19(6):537-43. doi: 10.1097/MCC.0000000000000028. Review.

PMID:
24240819
10.

Fluid replacement with hydroxyethyl starch in critical care--a reassessment.

Hartog CS, Welte T, Schlattmann P, Reinhart K.

Dtsch Arztebl Int. 2013 Jun;110(26):443-50. doi: 10.3238/arztebl.2013.0443. Epub 2013 Jun 28. Review.

11.

New insights into fluid resuscitation.

Myburgh J, McIntyre L.

Intensive Care Med. 2013 Jun;39(6):998-1001. doi: 10.1007/s00134-013-2890-3. Epub 2013 Apr 5.

PMID:
23559078
12.

Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality.

Patel A, Laffan MA, Waheed U, Brett SJ.

BMJ. 2014 Jul 22;349:g4561. doi: 10.1136/bmj.g4561. Review. Erratum in: BMJ. 2014;349:g4850.

13.

The COASST study: cost-effectiveness of albumin in severe sepsis and septic shock.

Guidet B, Mosqueda GJ, Priol G, Aegerter P.

J Crit Care. 2007 Sep;22(3):197-203. Epub 2007 Feb 8.

PMID:
17869969
14.

Hydroxyethyl starch versus other fluids for non-septic patients in the intensive care unit: a meta-analysis of randomized controlled trials.

He B, Xu B, Xu X, Li L, Ren R, Chen Z, Xiao J, Wang Y, Xu B.

Crit Care. 2015 Mar 19;19:92. doi: 10.1186/s13054-015-0833-9.

15.

Hydroxyethyl starch in severe sepsis: end of starch era?

Estrada CA, Murugan R.

Crit Care. 2013 Mar 13;17(2):310. doi: 10.1186/cc12531.

16.

Colloids versus crystalloids for fluid resuscitation in critically ill patients.

Perel P, Roberts I.

Cochrane Database Syst Rev. 2011 Mar 16;(3):CD000567. doi: 10.1002/14651858.CD000567.pub4. Review. Update in: Cochrane Database Syst Rev. 2012;6:CD000567.

PMID:
21412866
17.

Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis: a prospective sequential analysis.

Bayer O, Reinhart K, Kohl M, Kabisch B, Marshall J, Sakr Y, Bauer M, Hartog C, Schwarzkopf D, Riedemann N.

Crit Care Med. 2012 Sep;40(9):2543-51.

PMID:
22903091
18.

Colloid solutions for fluid resuscitation in patients with sepsis: systematic review of randomized controlled trials.

Zhong JZ, Wei D, Pan HF, Chen YJ, Liang XA, Yang ZY, Tang HB.

J Emerg Med. 2013 Oct;45(4):485-95. doi: 10.1016/j.jemermed.2013.05.018. Epub 2013 Aug 7. Review.

PMID:
23932700
19.

Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis.

Zarychanski R, Abou-Setta AM, Turgeon AF, Houston BL, McIntyre L, Marshall JC, Fergusson DA.

JAMA. 2013 Feb 20;309(7):678-88. doi: 10.1001/jama.2013.430. Review. Erratum in: JAMA. 2013 Mar 27;309(12):1229.

PMID:
23423413
20.

Clinical controversies in the management of critically ill patients with severe sepsis: resuscitation fluids and glucose control.

Finfer S.

Virulence. 2014 Jan 1;5(1):200-5. doi: 10.4161/viru.25855. Epub 2013 Aug 6. Review.

Supplemental Content

Support Center